These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 1888631)

  • 21. Metabolic interactions of putative cytochrome P4503A substrates with alternative pathways of dapsone metabolism in human liver microsomes.
    Irshaid Y; Branch RA; Adedoyin A
    Drug Metab Dispos; 1996 Feb; 24(2):164-171. PubMed ID: 8742227
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cimetidine interaction with liver microsomes in vitro and in vivo. Involvement of an activated complex with cytochrome P-450.
    Jensen JC; Gugler R
    Biochem Pharmacol; 1985 Jun; 34(12):2141-6. PubMed ID: 3924056
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of the metabolism and toxicity of dapsone in rat, mouse and man.
    Tingle MD; Mahmud R; Maggs JL; Pirmohamed M; Park BK
    J Pharmacol Exp Ther; 1997 Nov; 283(2):817-23. PubMed ID: 9353403
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of dapsone-induced methaemoglobinaemia by cimetidine in the presence of trimethoprim in the rat.
    Coleman MD; Russell RM; Tingle MD; Park BK
    J Pharm Pharmacol; 1992 Feb; 44(2):114-8. PubMed ID: 1352810
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential effects of cimetidine and ranitidine on imipramine demethylation and desmethylimipramine hydroxylation by human liver microsomes.
    Spina E; Koike Y
    Eur J Clin Pharmacol; 1986; 30(2):239-42. PubMed ID: 3709653
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bunitrolol metabolism and its inhibition by cimetidine.
    Ishida R; Fujita S; Suzuki T
    J Pharm Pharmacol; 1988 Jan; 40(1):64-5. PubMed ID: 2896780
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human liver microsomal N-hydroxylation of dapsone by cytochrome P-4503A4.
    Fleming CM; Branch RA; Wilkinson GR; Guengerich FP
    Mol Pharmacol; 1992 May; 41(5):975-80. PubMed ID: 1588928
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of cimetidine on hepatic cytochrome P450: evidence for formation of a metabolite-intermediate complex.
    Levine M; Bellward GD
    Drug Metab Dispos; 1995 Dec; 23(12):1407-11. PubMed ID: 8689952
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reduction of dapsone hydroxylamine to dapsone during methaemoglobin formation in human erythrocytes in vitro. III: Effect of diabetes.
    Coleman MD; Simpson J; Jacobus DP
    Biochem Pharmacol; 1994 Oct; 48(7):1341-7. PubMed ID: 7945431
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A dapsone-induced blood dyscrasia in the mouse: evidence for the role of an active metabolite.
    Ahmadi M; Khalaf LF; Smith HJ; Nicholls PJ
    J Pharm Pharmacol; 1996 Feb; 48(2):228-32. PubMed ID: 8935178
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytochrome P450-dependent toxicity of dapsone in human erythrocytes.
    Ganesan S; Sahu R; Walker LA; Tekwani BL
    J Appl Toxicol; 2010 Apr; 30(3):271-5. PubMed ID: 19998329
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Microsomal N-oxidation of dapson as a cause of methemoglobin formation in human red cells.
    Cucinell SA; Israili ZH; Dayton PG
    Am J Trop Med Hyg; 1972 May; 21(3):322-31. PubMed ID: 4554497
    [No Abstract]   [Full Text] [Related]  

  • 33. Cimetidine improves the therapeutic/toxic ratio of dapsone in patients on chronic dapsone therapy.
    Rhodes LE; Tingle MD; Park BK; Chu P; Verbov JL; Friedmann PS
    Br J Dermatol; 1995 Feb; 132(2):257-62. PubMed ID: 7888363
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of coumarin 7-hydroxylase activity in human liver microsomes.
    Draper AJ; Madan A; Parkinson A
    Arch Biochem Biophys; 1997 May; 341(1):47-61. PubMed ID: 9143352
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reduction of sulfamethoxazole and dapsone hydroxylamines by a microsomal enzyme system purified from pig liver and pig and human liver microsomes.
    Clement B; Behrens D; Amschler J; Matschke K; Wolf S; Havemeyer A
    Life Sci; 2005 May; 77(2):205-19. PubMed ID: 15862605
    [TBL] [Abstract][Full Text] [Related]  

  • 36. On the sulphoxidation of cimetidine and etintidine by rat and human liver microsomes.
    Schulz M; Schmoldt A
    Xenobiotica; 1988 Aug; 18(8):983-9. PubMed ID: 3142156
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of sulfamethoxazole hydroxylamine formation by fluconazole in human liver microsomes and healthy volunteers.
    Mitra AK; Thummel KE; Kalhorn TF; Kharasch ED; Unadkat JD; Slattery JT
    Clin Pharmacol Ther; 1996 Mar; 59(3):332-40. PubMed ID: 8653996
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bioactivation of benzocaine to a methaemoglobin-forming metabolite by rat and human microsomes in vitro.
    Coleman MD; Taylor CH
    Environ Toxicol Pharmacol; 1997 Feb; 3(1):47-52. PubMed ID: 21781757
    [TBL] [Abstract][Full Text] [Related]  

  • 39. N-hydroxylation of 4,4'-diaminodiphenylsulphone in liver microsomes and in vivo.
    Tabarelli S; Uehleke H
    Xenobiotica; 1971; 1(4):501-2. PubMed ID: 4152967
    [No Abstract]   [Full Text] [Related]  

  • 40. In vivo cimetidine inhibits hepatic CYP2C6 and CYP2C11 but not CYP1A1 in adult male rats.
    Levine M; Law EY; Bandiera SM; Chang TK; Bellward GD
    J Pharmacol Exp Ther; 1998 Feb; 284(2):493-9. PubMed ID: 9454789
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.